SII won't seek special marketing nod from EU body for vax

UK drug company, AstraZeneca, which developed the vaccine with Oxford University, has asked the regulator European Medicine Agency (EMA) to add SII as 'an alternative manufacturing site', on the approval given for its vaccine, Vaxzevria.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2U0dhPe
via IFTTT